Shift work, circadian gene variants and risk of breast cancer

Cancer Epidemiology

Volumn 37, Issue 5, 2013, Pages 606-612

  Grundy, Anne ^a   Schuetz, Johanna M ^b   Lai, Agnes S ^b   Janoo Gilani, Rozmin ^b   Leach, Stephen ^b   Burstyn, Igor ^c   Richardson, Harriet ^a   Brooks Wilson, Angela ^b,d   Spinelli, John J ^b,e   Aronson, Kristan J ^a  

^a QUEEN S UNIVERSITY   (Canada)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

^c DREXEL UNIVERSITY   (United States)

^d SIMON FRASER UNIVERSITY   (Canada)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Breast cancer; Case control; Clock genes; Interactions; Shift work

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RISK; CASE CONTROL STUDY; CIRCADIAN RHYTHM; CONTROLLED STUDY; ETHNICITY; FAMILY HISTORY; FEMALE; GENETIC ANALYSIS; GENETIC MODEL; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SHIFT WORKER; SINGLE NUCLEOTIDE POLYMORPHISM;

BREAST CANCER; CASE-CONTROL; CLOCK GENES; INTERACTIONS; SHIFT WORK;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; BRITISH COLUMBIA; CARCINOMA IN SITU; CASE-CONTROL STUDIES; CIRCADIAN CLOCKS; FEMALE; GENE-ENVIRONMENT INTERACTION; HUMANS; MIDDLE AGED; OCCUPATIONAL DISEASES; ONTARIO; POLYMORPHISM, SINGLE NUCLEOTIDE; WORK SCHEDULE TOLERANCE; YOUNG ADULT;

EID: 84884157338     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2013.04.006     Document Type: Article

References (58)

1. Fu L., Lee C.C. The circadian clock: pacemaker and tumour suppressor. Nat Rev Cancer 2003, 3(5):350-361.
2. Reppert S.M., Weaver D.R. Coordination of circadian timing in mammals. Nature 2002, 418(6901):935-941.
3. Reddy A.B., O'Neill J.S. Healthy clocks, healthy body, healthy mind. Trends Cell Biol 2010, 20(1):36-44.
4. Ünsal-Kaçmaz K., Mullen T.E., Kaufmann W.K., Sancar A. Coupling of human circadian and cell cycles by the timeless protein coupling of human circadian and cell cycles by the timeless protein. Mol Cell Biol 2005, 25.(8).
5. Dardente H., Cermakian N. Molecular circadian rhythms in central and peripheral clocks in mammals. Chronobiol Int 2007, 24(2):195-213.
6. Nakashima A., Kawamoto T., Honda K.K., Ueshima T., Noshiro M., Iwata T., et al. DEC1 modulates the circadian phase of clock gene expression. Mol Cell Biol 2008, 28(12):4080-4092.
7. Sahar S., Sassone-Corsi P. Circadian clock and breast cancer: a molecular link. Cell Cycle 2007, 6(11):1329-1331.
8. Gery S., Virk R.K., Chumakov K., Yu A., Koeffler H.P. The clock gene Per2 links the circadian system to the estrogen receptor. Oncogene 2007, 26(57):7916-7920.
9. Hoffman A.E., Zheng T., Ba Y., Zhu Y. The circadian gene NPAS2, a putative tumor suppressor, is involved in DNA damage response. Mol Cancer Res 2008, 6(9):1461-1468.
10. Lee C.C. Tumor suppression by the mammalian period genes. Cancer Causes Control 2006, 17(4):525-530.
11. Hua H., Wang Y., Wan C., Liu Y., Zhu B., Yang C., et al. Circadian gene mPer2 overexpression induces cancer cell apoptosis. Cancer Sci 2009, 97(7):589-596.
12. Gery S., Komatsu N., Baldjyan L., Yu A., Koo D., Koeffler H.P. The circadian gene per1 plays an important role in cell growth and DNA damage control in human cancer cells. Mol Cell 2006, 22(3):375-382.
13. Xiang S., Coffelt S.B., Mao L., Yuan L., Cheng Q., Hill S.M. Period-2: a tumor suppressor gene in breast cancer. J Circadian Rhythms 2008, 6(January):4.
14. Zhu Y., Brown H.N., Zhang Y., Stevens R.G., Zheng T. Period 3 structural variation: a circadian biomarker associated with breast cancer in young women. Cancer Epidemiol Biomarkers Prev 2005, 14(1):268-270.
15. Zhu Y., Stevens R.G., Leaderer D., Hoffman A., Holford T., Zhang Y., et al. Non-synonymous polymorphisms in the circadian gene NPAS2 and breast cancer risk. Breast Cancer Res Treat 2008, 107(3):421-425.
16. Hoffman A.E., Zheng T., Yi C.-H., Stevens R.G., Ba Y., Zhang Y., et al. The core circadian gene cryptochrome 2 influences breast cancer risk, possibly by mediating hormone signaling. Cancer Prev Res (Phila) 2010, 3(4):539-548.
17. Hoffman A.E., Yi C.-H., Zheng T., Stevens R.G., Leaderer D., Zhang Y., et al. CLOCK in breast tumorigenesis: genetic, epigenetic, and transcriptional profiling analyses. Cancer Res 2010, 70(4):1459-1468.
18. Fu A., Leaderer D., Zheng T., Hoffman A.E., Stevens R.G., Zhu Y., et al. Epigenetic associations of circadian gene TIMELESS and breast cancer risk. Mol Carcinog 2011, (May):1-7.
19. Monsees G.M., Kraft P., Hankinson S.E., Hunter D.J., Schernhammer E.S. Circadian genes and breast cancer susceptibility in rotating shift workers. Int J Cancer 2012, 617:1-40.
20. Chu L.W., Zhu Y., Yu K., Zheng T., Yu H., Zhang Y., et al. Variants in circadian genes and prostate cancer risk: a population-based study in China. Prostate Cancer Prostatic Dis 2008, 11(4):342-348.
21. Zhu Y., Stevens R.G., Hoffman A.E., Fitzgerald L.M., Kwon E.M., Ostrander E.a., et al. Testing the circadian gene hypothesis in prostate cancer: a population-based case-control study. Cancer Res 2009, 69(24):9315-9322.
22. Zhu Y., Leaderer D., Guss C., Brown H.N., Zhang Y., Boyle P., et al. Ala394Thr polymorphism in the clock gene NPAS2: a circadian modifier for the risk of non-Hodgkin's lymphoma. Int J Cancer 2006, 120(2):432-435.
23. Davis S., Mirick D.K., Stevens R.G. Night shift work, light at night, and risk of breast cancer. J Natl Cancer Inst 2001, 93(20):1557-1562.
24. Schernhammer E.S., Laden F., Speizer F.E., Willett W.C., Hunter D.J., Kawachi I., et al. Rotating night shifts and risk of breast cancer in women participating in the nurses' health study. J Natl Cancer Inst 2001, 93(20):1563-1568.
25. Hansen J. Increased breast cancer risk among women who work predominantly at night. Epidemiology 2001, 12(1):74-77.
26. Schernhammer E.S., Kroenke C.H., Laden F., Hankinson S.E. Night work and risk of breast cancer. Epidemiology 2006, 17(1):108-111.
27. Lie J.-A., Roessink J., Kjaerheim K. Breast cancer and night work among Norwegian nurses. Cancer Causes Control 2006, 17(1):39-44.
28. Lie J-AS, Kjuus H., Zienolddiny S., Haugen A., Stevens R.G., Kjærheim K. Night work and breast cancer risk among Norwegian nurses: assessment by different exposure metrics. Am J Epidemiol 2011, 173(11):1272-1279.
29. Hansen J., Stevens R.G. Case-control study of shift-work and breast cancer risk in Danish nurses: impact of shift systems. Eur J Cancer 2012, 48(11):1722-1729.
30. Pesch B., Harth V., Rabstein S., Baisch C., Schiffermann M., Pallapies D., et al. Night work and breast cancer - results from the German GENICA study. Scand J Work Environ Health 2010, 36(2):134-141.
31. Menegaux F., Truong T., Anger A., Cordina-Duverger E., Lamkarkach F., Arveux P., et al. Night work and breast cancer: a population-based case-control study in France (the CECILE study). Int J Cancer 2013, 132(4):924-931.
32. Fritschi L., Glass D.C., Heyworth J.S., Aronson K., Girschik J., Boyle T., et al. Hypotheses for mechanisms linking shiftwork and cancer. Med Hypotheses 2011, 77(3):430-436.
33. Stevens R.G. Circadian disruption and breast cancer. Epidemiology 2005, 16(2):254-258.
34. Schernhammer E.S., Berrino F., Krogh V., Secreto G., Micheli A., Venturelli E., et al. Urinary 6-sulfatoxymelatonin levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 2008, 100(12):898-905.
35. Schernhammer E.S., Hankinson S.E. Urinary melatonin levels and breast cancer risk. J Natl Cancer Inst 2005, 97(14):1084-1087.
36. Schernhammer E.S., Hankinson S.E. Urinary melatonin levels and postmenopausal breast cancer risk in the Nurses' Health Study cohort. Cancer Epidemiol Biomarkers Prev 2009, 18(1):74-79.
37. Schernhammer E.S., Berrino F., Krogh V., Secreto G., Micheli A., Venturelli E., et al. Urinary 6-Sulphatoxymelatonin levels and risk of breast cancer in premenopausal women: the ORDET cohort. Cancer Epidemiol Biomarkers Prev 2010, 19(3):729-737.
38. Travis R.C., Allen D.S., Fentiman I.S., Key T.J. Melatonin and breast cancer: a prospective study. J Natl Cancer Inst 2004, 96(6):475-482.
39. Honma S., Kawamoto T., Takagi Y., Fujimoto K. Dec1 and Dec2 are regulators of the mammalian molecular clock. Nature 2002, 419(July):841-844.
40. Griefahn B. The validity of the temporal parameters of the daily rhythm of melatonin levels as an indicator of morningness. Chronobiol Int 2002, 19(3):561-577.
41. Stevens R.G. Electric power use and breast cancer: a hypothesis. Am J Epidemiol 1987, 125(4):556-561.
42. De Bakker P.I.W., Yelensky R., Pe'er I., Gabriel S.B., Daly M.J., Altshuler D. Efficiency and power in genetic association studies. Nat Genet 2005, 37(November (11)):1217-1223.
43. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21(January (2)):263-265.
44. Purcell S., Neale B., Todd-Brown K., Thomas L., Ferreira M.a.R., Bender D., et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007, 81(September (3)):559-575.
45. Abecasis G.R., Cherny S.S., Cookson W.O., Cardon L.R. GRR: graphical representation of relationship errors. Bioinformatics 2001, 17(8):742-743.
46. Devlin B., Bacanu S.-A., Roeder K. Genomic control to the extreme. Nat Genet 2004, 36(11):1129-1131.
47. Devlin B., Roeder K., Wasserman L. Genomic control, a new approach to genetic-based association studies. Theor Pop Biol 2001, 60(3):155-166.
48. Devlin B., Roeder K., Wasserman L. Genomic control for association studies: a semiparametric test to detect excess-haplotype sharing. Biostatistics 2000, 1(4):369-387.
49. Thomas D.C., Witte J.S. Point: population stratification: a problem for case-control studies of candidate-gene associations?. Cancer Epidemiol Biomarkers Prev 2002, 11(6):505-512.
50. Anderson C.A., Pettersson F.H., Clarke G.M., Cardon L.R., Morris A.P., Zondervan K.T. Data quality control in genetic case-control association studies. Nat Protoc 2010, 5(9):1564-1573.
51. Schuetz J.M., Daley D., Graham J., Berry B.R., Gallagher R.P., Connors J.M., et al. Genetic variation in cell death genes and risk of non-Hodgkin lymphoma. PLoS ONE 2012, 7(2):e31560.
52. Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B Stat Methodol 1995, 57(1):289-300.
53. Greenland S., Rothman K.J. Introduction to stratified analysis. Modern epidemiology 1998, 253-279. Lippincott-Raven, Philadelphia. 2nd ed. K. Rothman, S. Greenland (Eds.).
54. Pronk A., Ji B.-T., Shu X.-O., Xue S., Yang G., Li H.-L., et al. Night-shift work and breast cancer risk in a cohort of Chinese women. Am J Epidmiol 2010, 171(9):953-959.
55. Bhatti P., Mirick D.K., Davis S. Racial differences in the association between night shift work and melatonin levels among women. Am J Epidemiol 2013, 177(5):388-393.
56. Grundy A., Bajdik C., Richardson H., Burstyn I., Lohrisch C., SenGupta S.K., et al. Shift work and breast cancer risk: Results from a Canadian case-control study. Occup Environ Med 2013, (accepted).
57. Zhu Y., Stevens R.G., Hoffman A.E., Tjonneland A., Vogel U.B., Zheng T., et al. Epigenetic impact of long-term shiftwork: pilot evidence from circadian genes and whole-genome methylation analysis. Chronobiol Int 2011, 28(10):852-861.
58. Reszka E., Peplonska B., Wieczorek E., Sobala W., Bukowska A., Gromadzinska J., et al. Circadian gene expression in peripheral blood leukocytes of rotating night shift nurses. Scand J Work Environ Health 2012, 39(2):187-194.